Saxenda (liraglutide) is a subcutaneous injection used for weight management in adults with obesity or overweight with weight-related comorbidities. Whilst the medication can be administered into three approved body areas—the abdomen, thigh, or upper arm—proper injection technique and systematic site rotation are essential for optimal treatment outcomes. Although pharmacokinetic studies show no clinically relevant absorption differences between these sites, repeatedly injecting into the same location can cause tissue damage, impairing drug delivery and reducing efficacy. Understanding correct injection practices helps maximise Saxenda's benefits whilst minimising complications such as lipohypertrophy, injection-site reactions, and discomfort. This article examines evidence-based guidance on Saxenda injection sites and technique.

Does It Matter Where You Inject Saxenda?

Yes, the injection site does matter when administering Saxenda (liraglutide). While Saxenda can be injected into several approved areas of the body, choosing the correct site and rotating between them is essential for optimal drug absorption and treatment efficacy. According to the Saxenda Summary of Product Characteristics (SmPC), there are three approved injection sites: the abdomen, thigh, and upper arm.

While the location you choose doesn't significantly affect how liraglutide enters your bloodstream (the SmPC indicates no clinically relevant pharmacokinetic differences between sites), proper technique and site rotation remain crucial. Repeatedly injecting into the same spot can lead to lipohypertrophy (lumpy tissue buildup) or lipoatrophy (tissue loss), which can impair drug absorption and may reduce Saxenda's effectiveness in managing weight.

Patients should understand that Saxenda is a subcutaneous injection (administered into the fatty tissue beneath the skin rather than into muscle). Injecting into damaged, scarred, or inflamed skin should be avoided, as this can cause discomfort and potential absorption issues. Proper injection technique is an important part of comprehensive weight management programmes.

For individuals new to Saxenda or self-injection, healthcare professionals should provide thorough training on identifying appropriate injection sites, proper needle insertion, and the importance of systematic site rotation. Understanding these fundamentals helps maximise treatment benefits whilst minimising injection-related complications such as bruising, pain, or nodule formation at injection sites.

Recommended Injection Sites for Saxenda

Saxenda should be injected subcutaneously into one of three approved body areas: the abdomen (stomach area), the front of the thighs, or the upper arms. Each site offers adequate subcutaneous tissue for proper drug delivery, though accessibility and patient preference may influence which area works best for individual circumstances.

The abdomen is often a popular choice and is generally considered an accessible site for self-administration. When injecting into the stomach area, select a site at least 5 cm (approximately two inches) away from the navel (belly button). Avoid injecting too close to the waistline or any areas with scars, moles, or skin abnormalities. The abdominal area typically provides sufficient subcutaneous fat in most patients.

The thigh represents another excellent option, particularly the front and outer aspects of the upper thigh. This site is easily accessible when sitting and allows good visualisation during injection. Avoid the inner thigh, as this area has more blood vessels and nerve endings, potentially causing increased discomfort. The thigh may be preferable for patients with limited abdominal subcutaneous tissue.

The upper arm (specifically the outer back portion) can be used, though this site may be more challenging for self-injection without assistance. Some patients find it difficult to reach comfortably or to pinch adequate skin in this area. If choosing the upper arm, ensure you can properly access the fatty tissue and maintain correct injection technique, or consider asking for assistance.

Regardless of which site you select, always inject into healthy, intact skin. Avoid areas that are bruised, tender, red, hard, scarred, or have stretch marks. Never inject directly into a muscle, as Saxenda is formulated specifically for subcutaneous administration.

How Injection Site Affects Saxenda Absorption

According to the Saxenda Summary of Product Characteristics (SmPC), there are no clinically relevant pharmacokinetic differences between injection sites (abdomen, thigh, or upper arm) for liraglutide. This means that when proper technique is maintained, the overall bioavailability remains similar across all approved sites.

Subcutaneous tissue health significantly influences drug absorption. While the specific sites themselves don't affect absorption in clinically meaningful ways, tissue damage from repeated injections in the same location can significantly impair absorption. Lipohypertrophy creates areas of altered tissue structure where blood flow is reduced and the subcutaneous architecture is disrupted. When Saxenda is injected into these damaged areas, absorption becomes unpredictable. This can lead to suboptimal drug levels and reduced efficacy in appetite suppression and weight management.

Individual patient factors may affect absorption, including body composition, subcutaneous fat distribution, and skin condition. Patients with very low body fat may have limited suitable injection sites, whilst those with obesity typically have ample subcutaneous tissue across all approved areas.

Maintaining consistent injection technique—including appropriate needle depth, injection speed, and allowing the medication to reach room temperature before injection (primarily for comfort)—helps ensure reliable absorption regardless of site selection. The most important factor for consistent absorption is not which of the three approved sites you choose, but rather systematically rotating your injections to prevent tissue damage.

Rotating Injection Sites: Why It Matters

Systematic rotation of injection sites is essential for anyone using Saxenda long-term. This practice prevents the development of lipohypertrophy and lipoatrophy, maintains consistent drug absorption, reduces injection discomfort, and minimises the risk of injection-site reactions. The Forum for Injection Technique (FIT UK) emphasises site rotation as a fundamental aspect of safe injection technique.

Lipohypertrophy develops when repeated trauma from injections causes localised fat tissue proliferation, creating lumpy, thickened areas under the skin. These areas feel firm or rubbery and can be visible as bumps or irregularities. Beyond cosmetic concerns, lipohypertrophy can disrupt drug absorption—studies in insulin users have shown that injecting into lipohypertrophic tissue can create unpredictable pharmacokinetics and affect medication efficacy.

To implement effective site rotation, divide each approved body area into multiple specific spots. For example, mentally divide your abdomen into quadrants (upper right, upper left, lower right, lower left) and rotate through these systematically. Keep at least 1 cm between injection points. Some patients find it helpful to maintain a simple diary or use their smartphone to track which site they used each day.

A practical rotation schedule might involve:

• Using the abdomen for injections on certain days

• Alternating to thighs on other days

• Systematically moving around within each chosen area

• Ensuring you rotate sites systematically to avoid reusing the same spot too frequently

Regularly inspect your injection sites by looking and feeling for any lumps, bumps, hardness, or skin changes. If you notice tissue abnormalities developing, avoid that area entirely until it returns to normal, which may take several weeks or months. Report persistent changes to your GP or practice nurse, as they may need to reassess your injection technique or provide additional guidance on site selection and rotation strategies.

Common Mistakes When Injecting Saxenda

Understanding and avoiding common injection errors helps maximise Saxenda's effectiveness whilst minimising discomfort and complications. One of the most frequent mistakes is repeatedly using the same injection site or area, often because it feels familiar or comfortable. This inevitably leads to tissue damage and impaired absorption. Patients should consciously vary their injection location with each dose.

Injecting too quickly represents another common error. According to the Saxenda Patient Information Leaflet, the injection should be administered slowly and steadily, with the needle remaining in place for at least 6 seconds after fully depressing the dose button. Rushing the injection or withdrawing the needle too quickly can result in medication leaking back out, meaning you receive less than the prescribed dose. Some patients notice a small amount of liquid at the injection site after withdrawal—whilst a tiny droplet is normal, larger amounts suggest technique problems.

Using incorrect technique for your body type can result in intramuscular rather than subcutaneous injection. According to FIT UK recommendations, most adults can use a short needle (4mm) at a 90-degree angle without pinching the skin. However, if you are very lean or using a longer needle, you may need to pinch the skin and/or use a 45-degree angle—discuss this with your healthcare provider.

Injecting cold medication directly from the refrigerator increases injection discomfort. Allow the Saxenda pen to reach room temperature (approximately 30 minutes out of the fridge) before injecting. However, never heat the medication artificially or leave it in direct sunlight.

Other important mistakes to avoid include:

• Reusing needles (always use a fresh needle for each injection)

• Injecting through clothing rather than into clean, exposed skin

• Failing to check the medication for particles or discolouration before injection

• Not priming the pen properly before first use

• Injecting into areas with active skin conditions, infections, or inflammation

If you experience persistent pain, bleeding, bruising, or signs of infection (redness, warmth, swelling, pus) at injection sites, contact your GP promptly. Similarly, if you notice your Saxenda seems less effective at controlling appetite or supporting weight loss, discuss your injection technique with your healthcare provider.

If you suspect any side effects from Saxenda, report them via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk).

Frequently Asked Questions